Quarterly report pursuant to Section 13 or 15(d)

Net Loss per Share (Details)

v3.23.3
Net Loss per Share (Details) - shares
shares in Thousands
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Convertible debt    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share amount 10,928 7,451
Restricted and performance stock units    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share amount 37,177 33,257
Restricted common stock shares    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share amount 0 3,019
Early exercise of unvested stock options    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share amount 69 870
Options to purchase common stock    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share amount 110 197